DE69732760D1 - Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern - Google Patents

Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern

Info

Publication number
DE69732760D1
DE69732760D1 DE69732760T DE69732760T DE69732760D1 DE 69732760 D1 DE69732760 D1 DE 69732760D1 DE 69732760 T DE69732760 T DE 69732760T DE 69732760 T DE69732760 T DE 69732760T DE 69732760 D1 DE69732760 D1 DE 69732760D1
Authority
DE
Germany
Prior art keywords
drug
vaginal
core
containing core
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732760T
Other languages
English (en)
Other versions
DE69732760T2 (de
Inventor
Saleh Ismail Saleh
Harold Nash
Wayne Bardin
Troy Harmon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Population Council Inc
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of DE69732760D1 publication Critical patent/DE69732760D1/de
Publication of DE69732760T2 publication Critical patent/DE69732760T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
DE69732760T 1996-07-31 1997-07-22 Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern Expired - Lifetime DE69732760T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2379296P 1996-07-31 1996-07-31
US23792P 1996-07-31
US08/850,327 US5972372A (en) 1996-07-31 1997-05-02 Intravaginal rings with insertable drug-containing core
US850327 1997-05-02
PCT/US1997/012777 WO1998004220A1 (en) 1996-07-31 1997-07-22 Intravaginal rings with insertable drug-containing core

Publications (2)

Publication Number Publication Date
DE69732760D1 true DE69732760D1 (de) 2005-04-21
DE69732760T2 DE69732760T2 (de) 2006-04-13

Family

ID=26697614

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732760T Expired - Lifetime DE69732760T2 (de) 1996-07-31 1997-07-22 Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern

Country Status (13)

Country Link
US (2) US5972372A (de)
EP (1) EP0862396B1 (de)
JP (1) JP3970936B2 (de)
CN (1) CN1154455C (de)
AT (1) ATE290836T1 (de)
AU (1) AU4043197A (de)
BR (1) BR9706802A (de)
CA (1) CA2232635C (de)
DE (1) DE69732760T2 (de)
DK (1) DK0862396T3 (de)
ES (1) ES2239363T3 (de)
PT (1) PT862396E (de)
WO (1) WO1998004220A1 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537566B1 (en) 1999-03-11 2003-03-25 John Alton Copland Compositions and methods for the non-invasive treatment of uterine fibroid cells
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
WO2003017971A1 (en) * 2001-08-31 2003-03-06 Schering Oy Drug delivery system
US9993424B2 (en) * 2002-03-27 2018-06-12 Allergan Pharmaceuticals International Limited Intravaginal matrix drug delivery devices
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
CA2523859C (en) * 2003-04-29 2011-08-02 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
CA2531640C (en) * 2003-07-10 2013-06-18 Galen (Chemicals) Limited Intravaginal drug delivery devices
DE602005026290D1 (de) * 2004-07-09 2011-03-24 Population Council Inc Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20060185678A1 (en) * 2005-02-03 2006-08-24 Bronnenkant Lance J Devices for delivering agents to a vaginal tract
EP2246062B1 (de) 2005-07-19 2012-09-26 The Population Council, Inc. Verfahren und Zusammensetzungen zur notfallbedingten Verhütung mithilfe von Endothelin-Rezeptor-Antagonisten
CA2618349C (en) * 2005-08-11 2016-05-31 Massachusetts Institute Of Technology Intravesical drug delivery device and method
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
BRPI0709344A2 (pt) * 2006-03-20 2011-07-12 Duramed Pharmaceuticals Inc anel intravaginal comprimido flexìvel, seu uso e processo de preparação, método de fornecer um agente ativo, kit terapêutico e produto
US8399012B2 (en) 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
BRPI0713203A2 (pt) * 2006-07-12 2012-04-03 Controlled Therapeutics Scotland Ltda inserto, métodos, embalagem, dispositivo recuperável e dispositivo inserìvel
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
WO2008021338A2 (en) * 2006-08-15 2008-02-21 Wyeth Tricyclic oxazolidone derivatives useful as pr modulators
WO2008021339A2 (en) * 2006-08-15 2008-02-21 Wyeth Pyrrolidine and related derivatives useful as pr modulators
US7652018B2 (en) * 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
KR20090110355A (ko) * 2007-01-19 2009-10-21 더 유니버시티 오브 유타 리서치 파운데이션 치료제 전달용 생분해성 질내 기구
CN101827581A (zh) 2007-06-26 2010-09-08 沃纳奇尔科特有限责任公司 用于递送大分子和水溶性药物的阴道内药物递送装置
AR066166A1 (es) * 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
DK2062569T3 (da) * 2007-11-22 2011-08-29 Bayer Oy Vaginalt afgivelsessystem
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
JP5560200B2 (ja) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
SG10201605171QA (en) * 2008-02-04 2016-08-30 Ferring Bv Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
CN102176931B (zh) 2008-08-09 2015-03-04 麻省理工学院 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8420153B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US20120070476A1 (en) * 2009-05-29 2012-03-22 Moench Thomas R Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
CN102596097B (zh) 2009-06-03 2015-05-20 弗赛特实验室有限责任公司 一种眼插入件
SG177360A1 (en) 2009-06-26 2012-02-28 Taris Biomedical Inc Implantable drug delivery devices and methods of making the same
US8753667B2 (en) * 2009-07-21 2014-06-17 The Population Council, Inc. Multi-layered gradient vaginal ring
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US20130096092A1 (en) 2010-06-10 2013-04-18 Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
TW201212939A (en) * 2010-06-22 2012-04-01 Anu Mahashabde Intravaginal devices comprising anticholinergic agents, and methods of making thereof
WO2012024461A2 (en) * 2010-08-20 2012-02-23 Teva Women's Health, Inc. Intravaginal devices, methods of making, and uses thereof
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CA2817713C (en) 2010-11-12 2018-12-04 The University Of Utah Research Foundation Intravaginal devices for controlled delivery of lubricants
RU2620032C2 (ru) 2011-01-10 2017-05-22 Аллерган, Инк. Схема приема лидокаина для применения в продолжительном лечении боли в мочевом пузыре и раздражения при мочеиспускании
CN103379902B (zh) * 2011-02-04 2015-11-25 塔里斯生物医药公司 用于低溶解度药物的控制释放的可植入装置
KR102059698B1 (ko) * 2011-06-06 2019-12-26 오크 크레스트 인스티튜트 오브 사이언스 심지 방출창을 도입한 약물 전달 장치
WO2013029194A1 (es) 2011-08-26 2013-03-07 Universidad De Santiago De Chile Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer
KR102071083B1 (ko) 2011-09-14 2020-01-29 포사이트 비젼5, 인크. 안내 삽입물 장치 및 방법
EP3936133A1 (de) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natürliche kombinationshormonersatzformulierungen und therapien
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
TW201332585A (zh) * 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
EP2641602A1 (de) 2012-03-23 2013-09-25 PregLem S.A. Verfahren zur Behandlung gynäkologischer Leiden
DE102012009057A1 (de) * 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
DK2893804T3 (en) 2012-09-03 2018-07-02 Ecosea Farming S A Reservoir cage immersion system for growing and / or containment of hydrobiological species
CN104884006B (zh) 2012-10-26 2017-12-15 弗赛特影像5股份有限公司 用于持续释放药物到眼睛的眼科系统
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
EP2953629A1 (de) 2013-02-05 2015-12-16 The Population Council, Inc. Intravaginalring zur abgabe einzelner kombinationen von antimikrobiellen zusammensetzungen
WO2014122563A1 (en) * 2013-02-08 2014-08-14 Qpharma Ab An intra vaginal device, and a method of reducing the rate of diffusion of active ingredients in said intra vaginal device
ES2949133T3 (es) * 2013-03-08 2023-09-25 Li Galli B V I O Sistema de diagnóstico y/o administración de fármacos vaginales
KR102293280B1 (ko) 2013-03-15 2021-08-23 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치 및 방법
CN105120874A (zh) 2013-04-10 2015-12-02 普雷格莱姆股份有限公司 孕酮受体调节剂在子宫肌瘤疗法中的用途
RS60847B1 (sr) 2013-08-19 2020-10-30 Taris Biomedical Llc Uređaji za davanje više jedinica leka
WO2015035003A1 (en) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
SE539540C2 (sv) 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
WO2015055789A1 (en) 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
AU2015211356B2 (en) 2014-01-28 2020-04-16 The Population Council, Inc. Combination product for the prevention of sexually transmitted infections
CA3208334A1 (en) * 2014-04-01 2015-10-08 Poly-Med, Inc. Contraceptive and related device
US20150306230A1 (en) * 2014-04-28 2015-10-29 Celanese Acetate Llc Drug delivery vehicles comprising cellulose derivatives, starch derivatives, and combinations thereof
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
DK2982352T3 (en) * 2014-06-28 2018-11-26 Laboratorios Andromaco S A CERVICALLY PESSAR CONTAINING PROGESTERON FOR EXTENDED, LONG AND CONTINUOUS RELEASE USED TO PREVENT EARLY BIRTHS
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
JP7425534B2 (ja) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
US20200337888A1 (en) 2017-10-27 2020-10-29 Renovia Inc. Devices, systems, and methods for training pelvic floor muscles
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US11529308B2 (en) * 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
US10918649B2 (en) * 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
CN114980861A (zh) * 2019-11-27 2022-08-30 橡冠科学研究院 缓释药物递送装置
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
USD935018S1 (en) * 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3991760A (en) * 1975-12-02 1976-11-16 The Procter & Gamble Company Vaginal medicament dispensing means
US3995633A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
JPS5339064U (de) * 1976-09-08 1978-04-05
US4286587A (en) * 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4250611A (en) * 1979-04-19 1981-02-17 Alza Corporation Process for making drug delivery device with reservoir
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
CA2232635A1 (en) 1998-02-05
EP0862396A4 (de) 2000-09-06
CN1154455C (zh) 2004-06-23
AU4043197A (en) 1998-02-20
MX9802349A (es) 1998-08-30
DE69732760T2 (de) 2006-04-13
CN1198091A (zh) 1998-11-04
ATE290836T1 (de) 2005-04-15
BR9706802A (pt) 1999-08-31
DK0862396T3 (da) 2005-07-11
JPH11512965A (ja) 1999-11-09
ES2239363T3 (es) 2005-09-16
WO1998004220A1 (en) 1998-02-05
PT862396E (pt) 2005-07-29
US5972372A (en) 1999-10-26
US6126958A (en) 2000-10-03
EP0862396A1 (de) 1998-09-09
CA2232635C (en) 2002-09-17
EP0862396B1 (de) 2005-03-16
JP3970936B2 (ja) 2007-09-05

Similar Documents

Publication Publication Date Title
DE69732760D1 (de) Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern
KR100312764B1 (ko) 질내전달시스템
US4186742A (en) Contraceptive-antivenereal disease tampon
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
CA2119252A1 (en) Controlled porosity implantable primary lumen device
BRPI0015284B8 (pt) formulações de hidrocodona de liberação controlada
CA2222133A1 (en) Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
IE860306L (en) Drug delivery system
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
CA2233753A1 (en) Drug delivery system for two or more active substances
CA2292402A1 (en) Intra-vaginal device for pigs
SE8803087D0 (sv) A new method of treating erectile dysfunction
ES2001391A6 (es) Procedimiento de obtencion de una composicion farmaceutica para el tratamiento de senos faciales y nasales, alergias y sintomas de resfriado.
CA2352552A1 (en) Treatment of erectile dysfunction
BG101553A (en) Progesterone antagonist and antiestrogenous active compounds of general application for female contraceptives
CO5261567A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas
WO2000042942A3 (en) Buccal drug delivery system for use in male contraception
NZ333750A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
IE801903L (en) Drug delivery device
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
MY124465A (en) Reduction of infarct volume using citicoline
GR900100489A (el) Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition